S-Adenosylmethionine attenuates lipopolysaccharide-induced liver injury by downregulating the Toll-like receptor 4 signal in Kupffer cells

Hepatology International

Volumn 8, Issue 2, 2014, Pages 275-284

  Li, Peizhi ^a   Zhang, Zhao ^a   Gong, Jianping ^a   Zhang, Yan ^a   Zhu, Xiwen ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Liver injury; S Adenosylmethionine; Toll like receptor 4; Tumor necrosis factor

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; MYELOID DIFFERENTIATION FACTOR 88; S ADENOSYLMETHIONINE; TOLL LIKE RECEPTOR 4;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CELL DIFFERENTIATION; CELL ISOLATION; CELL NUCLEUS; DOWN REGULATION; DRUG MECHANISM; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOHISTOCHEMISTRY; KUPFFER CELL; LIVER INJURY; LIVER PROTECTION; LIVER SINUSOID; MALE; MOUSE; MYD88 GENE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; SURVIVAL RATE; TLR4 GENE; WESTERN BLOTTING;

EID: 84899941091     PISSN: 19360533     EISSN: 19360541     Source Type: Journal    
DOI: 10.1007/s12072-014-9528-6     Document Type: Article

References (25)

1. Wang L, Zhu R, Huang Z, Li H, Zhu H. Lipopolysaccharide-induced toll-like receptor 4 signaling in cancer cells promotes cell survival and proliferation in hepatocellular carcinoma. Dig Dis Sci 2013;58:2223-2236
2. Su GL. Lipopolysaccharides in liver injury: molecular mechanisms of Kupffer cell activation. Am J Physiol Gastrointest Liver Physiol 2002;283:G256-G265 (Pubitemid 34791290)
3. Wynn TA, Chawla A, Pollard JW. Macrophage biology in development, homeostasis and disease. Nature 2013;25(496):445-455
4. Yee SB, Ganey PE, Roth RA. The role of Kupffer cells and TNFalpha in monocrotaline and bacterial lipopolysaccharide-induced liver injury. Toxicol Sci Off J Soc Toxicol 2003;71:124-132 (Pubitemid 36163712)
5. Baffy G. Kupffer cells in non-alcoholic fatty liver disease: the emerging view. J Hepatol 2009;51:212-223
6. Lu SC, Mato JM. S-Adenosylmethionine in liver health, injury, and cancer. Physiol Rev 2012;92:1515-1542
7. Song Z, Barve S, Chen T, et al. S-Adenosylmethionine (AdoMet) modulates endotoxin stimulated interleukin-10 production in monocytes. Am J Physiol Gastrointest Liver Physiol 2003;284:G949-G955 (Pubitemid 36597337)
8. Anstee QM, Day CP. S-Adenosylmethionine (SAMe) therapy in liver disease: a review of current evidence and clinical utility. J Hepatol 2012;57:1097-1109
9. Palsson-McDermott EM, O'Neill LA. Signal transduction by the lipopolysaccharide receptor, Toll-like receptor-4. Immunology 2004;113:153-162 (Pubitemid 39312442)
10. O'Neill LA, Golenbock D, Bowie AG. The history of Toll-like receptors - redefining innate immunity. Nat Rev Immunol 2013;13:453-460
11. Oliva J, Bardag-Gorce F, Li J, French BA, French SW. S-Adenosylmethionine prevents the up regulation of Toll-like receptor (TLR) signaling caused by chronic ethanol feeding in rats. Exp Mol Pathol 2011;90:239-243
12. Xu FL, You HB, Li XH, Chen XF, Liu ZJ, Gong JP. Glycine attenuates endotoxin-induced liver injury by downregulating TLR4 signaling in Kupffer cells. Am J Surg 2008;196:139-148 (Pubitemid 351847786)
13. Liu ZJ, Liu XL, Zhao J, et al. The effects of SOCS-1 on liver endotoxin tolerance development induced by a low dose of lipopolysaccharide are related to dampen NF-kappaB-mediated pathway. Dig Liver Dis 2008;40:568-577
14. Wei S, Huang Q, Li J, et al. Taurine attenuates liver injury by downregulating phosphorylated p38 MAPK of Kupffer cells in rats with severe acute pancreatitis. Inflammation 2012;35:690-701
15. Hellemans J, Mortier G, De Paepe A, Speleman F, Vandesompele J. qBase relative quantification framework and software for management and automated analysis of real-time quantitative PCR data. Genome Biol 2007;8:R19
16. Wang HL, Zhang WH, Lei WF, Zhou CQ, Ye T. The inhibitory effect of lidocaine on the release of high mobility group box 1 in lipopolysaccharide- stimulated macrophages. Anesth Analg 2011;112:839-844
17. Fabre C, Mimura N, Bobb K, et al. Dual inhibition of canonical and noncanonical NF-kappaB pathways demonstrates significant antitumor activities in multiple myeloma. Clinical Cancer Res Off J Am Assoc Cancer Res 2012;1(18):4669-4681
18. Song Z, Uriarte S, Sahoo R, et al. S-Adenosylmethionine (SAMe) modulates interleukin-10 and interleukin-6, but not TNF, production via the adenosine (A2) receptor. Biochim Biophys Acta 2005;15(1743):205-213
19. Watson WH, Zhao Y, Chawla RK. S-Adenosylmethionine attenuates the lipopolysaccharide-induced expression of the gene for tumour necrosis factor alpha. Biochem J 1999;342(Pt 1):21-25 (Pubitemid 29410844)
20. Ara AI, Xia M, Ramani K, Mato JM, Lu SC. S-Adenosylmethionine inhibits lipopolysaccharide-induced gene expression via modulation of histone methylation. Hepatology 2008;47:1655-1666 (Pubitemid 351702748)
21. Chawla RK, Watson WH, Eastin CE, Lee EY, Schmidt J, McClain CJ. S-Adenosylmethionine deficiency and TNF-alpha in lipopolysaccharide-induced hepatic injury. Am J Physiol 1998;275:G125-G129
22. Shih VF, Tsui R, Caldwell A, Hoffmann A. A single NF-kappaB system for both canonical and non-canonical signaling. Cell Res 2011;21:86-102
23. Veal N, Hsieh CL, Xiong S, Mato JM, Lu S, Tsukamoto H. Inhibition of lipopolysaccharide-stimulated TNF-alpha promoter activity by S-adenosylmethionine and 5′-methylthioadenosine. Am J Physiol Gastrointest Liver Physiol 2004;287:G352-G362 (Pubitemid 38955255)
24. Ko K, Yang H, Noureddin M, et al. Changes in S-adenosylmethionine and GSH homeostasis during endotoxemia in mice. Lab Investig 2008;88:1121-1129
25. Gobejishvili L, Avila DV, Barker DF, et al. S-Adenosylmethionine decreases lipopolysaccharide-induced phosphodiesterase 4B2 and attenuates tumor necrosis factor expression via cAMP/protein kinase A pathway. J Pharmacol Exp Ther 2011;337:433-443